CHLOR-TRIMETON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlor-trimeton, and when can generic versions of Chlor-trimeton launch?
Chlor-trimeton is a drug marketed by Schering Plough, Schering, and Bayer Healthcare Llc. and is included in five NDAs.
The generic ingredient in CHLOR-TRIMETON is chlorpheniramine maleate; pseudoephedrine sulfate. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; pseudoephedrine sulfate profile page.
Summary for CHLOR-TRIMETON
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 46 |
Clinical Trials: | 1 |
Patent Applications: | 5,866 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CHLOR-TRIMETON at DailyMed |
Recent Clinical Trials for CHLOR-TRIMETON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Auburn University | Early Phase 1 |